EULAR® 2024 Insights

 

Rheumatoid Arthritis
09:48

EULAR® 2024 Insights

Understanding the Psychosocial Determinants of Effective Disease Management in Rheumatoid Arthritis: A Qualitative Study

FEATURING Mrinalini Dey, Elena Nikiphorou
  • 102 views
  • July 24, 2024
  • 1
22:09

EULAR® 2024 Insights

EULAR® 2024 Insights: EULAR Recommendations Regarding Lifestyle Behaviors and Work Participation to Prevent Progression of Rheumatic and Musculoskeletal Diseases

FEATURING Suzanne Verstappen
  • 69 views
  • July 16, 2024
11:04

EULAR® 2024 Insights

EULAR® 2024 Insights - Challenging the Difficult-to-Treat Rheumatoid Arthritis: Comparative Analysis of Clinical Efficacy and Drug Retention of Subsequent Biologic and Targeted Synthetic Disease-modifying Anti-rheumatic Drugs

FEATURING Ladislav Šenolt
  • 89 views
  • July 2, 2024
23:14

EULAR® 2024 Insights

EULAR® 2024 Insights: BiTEing RA & Immunosuppressants for Infections in Inflammatory Arthritis

FEATURING Diane Van Der Woude
  • 100 views
  • July 2, 2024
07:59

EULAR® 2024 Insights

Difficult-to-Treat Rheumatoid Arthritis

FEATURING Jaap Van Laar
  • 276 views
  • June 26, 2024
  • 1
18:10

EULAR® 2024 Insights

EULAR® 2024 Insights - Women with RA and Menopause: Results of an NRAS Survey

FEATURING Sharon Petford
  • 7 views
  • June 21, 2024
08:57

EULAR® 2024 Insights

EULAR® 2024 Insights: Machine Learning to Characterize Bone Biomarkers Profile in Rheumatoid Arthritis

FEATURING Giovanni Adami
  • 56 views
  • June 21, 2024
09:37

EULAR® 2024 Insights

EULAR® 2024 Insights - Deciphering the Clinical Quandary: A Cross-Sectional Study on the Prevalence and Attributes of Difficult-to-Treat Rheumatoid Arthritis

FEATURING Hajar Elhani
  • 121 views
  • June 19, 2024
  • 1
06:08

EULAR® 2024 Insights

EULAR® 2024 Insights - Interception of the Development of RA by a 1-Year Course of Methotrexate in ACPA-Negative Arthralgia Patients at Increased Risk for RA: 4 Year Results of the TREAT EARLIER Trial

FEATURING Quirine Dumoulin
  • 83 views
  • June 18, 2024